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Latent Gammaherpesvirus 68 Infection Induces Distinct
Transcriptional Changes in Different Organs
Susan P. Canny,a Gautam Goel,b,c Tiffany A. Reese,a Xin Zhang,a Ramnik Xavier,b,c Herbert W. Virgina
‹Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USAa; Center for Computational and Integrative Biology and
Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USAb; Program in Medical and Population Genetics, Broad Institute
of MIT and Harvard, Cambridge, Massachusetts, USAc
Previous studies identified a role for latent herpesvirus infection in cross-protection against infection and exacerbation of
chronic inflammatory diseases. Here, we identified more than 500 genes differentially expressed in spleens, livers, or brains of
mice latently infected with gammaherpesvirus 68 and found that distinct sets of genes linked to different pathways were altered
in the spleen compared to those in the liver. Several of the most differentially expressed latency-specific genes (e.g., the gamma
interferon [IFN-], Cxcl9, and Ccl5 genes) are associated with known latency-specific phenotypes. Chronic herpesvirus infec-
tion, therefore, significantly alters the transcriptional status of host organs. We speculate that such changes may influence host
physiology, the status of the immune system, and disease susceptibility.
Herpesviruses transit between lytic and latent life cycles andcause lifelong infection of their hosts. Following acute lytic
infection of various cell types, herpesviruses establish latency, de-
fined experimentally as the presence of the viral genome without
production of infectious virus (1). Humans are chronically in-
fected with numerous viruses, including several herpesviruses (1).
However, the effect of chronic viral infection on the host is not
well understood. We and others have shown that latent viral in-
fection can protect hosts from lethal challenges with bacteria and
lymphoma cells (2–4). This latency-induced cross-protection is
associated with activation of macrophages, production of the in-
flammatory cytokine, gamma interferon (IFN-), and arming of
natural killer cells (2, 3). Latent murine gammaherpesvirus 68
(MHV68, HV-68, MuHV-4) also modulates adenovirus and
plasmodium infections (5, 6). MHV68 is implicated in exacerbat-
ing experimental autoimmune encephalomyelitis (EAE), a rodent
model for multiple sclerosis (7, 8), as well as a mouse model of
inflammatory bowel disease (9). Together, these studies are con-
sistent with chronic or latent herpesvirus infection having sub-
stantial effects on host immune responses to unrelated antigens.
This led us to determine whether latent herpesvirus infection in-
duces distinct transcriptional changes in specific organs by ana-
lyzing microarray data from RNA extracted from spleens, livers,
and brains of mice infected with MHV68 or a mutant MHV68
virus with a stop codon in open reading frame 73 (ORF73)
(ORF73.stop) that undergoes acute replication but is defective in
the establishment of latency (10, 11).
Chronic MHV68 infection alters the host transcriptional
profile. To determine whether chronic MHV68 infection alters
the host transcriptional profile in various organs, we infected 7- to
9-week-oldmale C57BL/6Jmice intranasally withwild-type (WT)
MHV68, ORF73.stop mutant virus, or “mockulum” (mock) as
previously described (2). After cardiac perfusion with phosphate-
buffered saline (PBS) to diminish numbers of peripheral blood
cells in tissue, brains, livers, and spleens were harvested at 28 days
postinfection (dpi), a time point at which we know that latency is
established and at which cross-protection against bacteria is ap-
parent (2–4, 12). Mice were handled in accordance with federal
and Washington University regulations.
To identify the gene signature of latent infection, we analyzed
the microarray data using two methods: (i) factorial analysis to
identify genes with significant fold change differences between
wild-type (WT) MHV68-infected mice and ORF73.stop-infected
mice and (ii) a two-way analysis of variance (ANOVA) to identify
genes that were significantly differentially expressed due to the
type of tissue, the virus, or the combination of these two factors (P
value 0.05 for reported genes in each analysis). Differential ex-
pression analysis was performed in the MATLAB software envi-
ronment. For both analyses, differentially expressed genes were
identified by first comparingmock-infectedmice tomice infected
with ORF73.stop or WT MHV68. Next, we compared the gene
expression profiles of differentially expressed genes frommice in-
fected with ORF73.stop virus to those for mice infected with WT
MHV68 to identify a set of genes specifically differentially ex-
pressed in mice that were infected with the latency-sufficient WT
MHV68. We considered this set of genes to be specific to latent
infection. Five hundred fifty-two genes were identified by both
methods as differentially expressed in virus-infected hosts, andwe
considered this our high-confidence gene set (Fig. 1; see also Data
Set S1 in the supplementalmaterial). Of these 552 genes, 550 genes
were specifically differentially expressed in latently infected ani-
mals and 2 genes were specifically differentially expressed in
ORF73.stop-infected mice.
Some genes are regulated with oscillations in the circadian
rhythm. In fact, a recent study delineated a role for the circadian
clock in expression and function of an innate immune response
gene, encoding Toll-like receptor 9, highlighting the importance
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of controlling for diurnal gene regulation in studies of infection
and immunity (13). Since two of the liver and spleen data sets were
consistently collected in either the morning or afternoon, we in-
cluded a third data set for which all samples were collected within
2 h. We also computationally tested whether circadian rhythm
genes were present in our list of genes regulated by latent infec-
tion. Only 3 of 67 genes related to circadian rhythm in MSigDB
(Molecular Signatures Database) were present in our list of laten-
cy-specific host genes, indicating that the time of harvest did not
significantly confound our results.
To confirm the reproducibility of the latency-specific differen-
tial gene expression that we observed, we compared our gene ex-
pression signature in the spleens of latently infected mice to a
complementary data set of gene expression in spleens of latently
infected mice, independently generated by another group (14).
Therewere 309 genes in commonbetween these twodata sets (P
1.8876e24 by a hypergeometric test). Furthermore, we used a
direct quantitative correlation computation to compare the data
sets. Since the data sets were profiled on distinct platforms (Illu-
mina versus Affymetrix), we identified themost similar probes on
the two platforms using the Smith-Waterman local alignment al-
gorithm to compute a sequence nucleotide alignment score. After
selecting matched pairs of probes, we evaluated the correlation
between fold change in expression as observed in the two data sets.
The regression coefficient between the comparable sets of datawas
0.67. Together, these analyses demonstrate a significant overlap
between spleen data sets generated using distinct platforms at dif-
ferent institutions and indicate that the gene expression changes
we identified are robust. Our data extend these findings by ana-
lyzing gene expression in additional tissues, specifically the liver
and brain.
To further validate our microarray findings, we selected 10
genes that we identified as specifically differentially expressed in
latently infected animals for confirmation by quantitative real-
time PCR (qRT-PCR) (Fig. 2 and Table 1). Genes were selected to
encompass a range of fold changes and differential expression
patterns (some specific to the spleen, some specific to the liver, and
some differentially expressed in both tissues) and relationship to
known pathways (e.g., IFN- signaling) or diseases (e.g., genome-
wide association studies of multiple sclerosis or celiac disease) of
interest. Our analyses predicted that the basic leucine zipper tran-
scription factor, ATF-like (Batf), IFN-, and the interleukin 18
receptor accessory protein (Il18rap) were upregulated in the
spleens of latently infected mice; vascular cell adhesion molecular
1 (Vcam1), spleen tyrosine kinase (Syk), and pleckstrin (Plek)
were upregulated in the livers of latently infected mice; and










































































FIG 1 Latent MHV68 alters host gene expression. Male C57BL/6 mice were
infected intranasally with MHV68, ORF73.stop mutant virus (ORF73), or
mockulum (mock), and spleens, livers, and brains (3 experiments) were har-
vested at 28 dpi. RNA was extracted using the ToTALLY RNA kit (Ambion)
from tissues incubated in RNAlater-ICE (Ambion). Equal amounts of RNA
were pooled from three to four mice per condition for each microarray chip.
RNA was labeled and hybridized to Affymetrix M430 2.0 microarrays at the
MultiplexedGeneAnalysis Core Facility atWashingtonUniversity in St. Louis,
MO. Data were normalized using the Robust Multi-array Average normaliza-
tion routine in Affymetrix’s Expression Console software. Microarray data
were analyzed by both factorial analysis and two-way ANOVA. Differentially
expressed genes identified by both analyses are shown in the heat map after
hierarchical clustering of the genes. The heat map represents the fold change
relative to results for mock-infected mice, with red representing the rowmax-
imumandblue the rowminimumvalue. Statistical significancewas performed
by using a standard Student t test in the case of factorial analysis. P values were
corrected for multiple hypothesis testing. Gene expression differences were
considered significant if the adjusted P value was 0.05 and a 1.5-fold
change was observed in expression levels.
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GTPase 1 (Iigp1), and guanylate binding protein 1 (Gbp1) were
upregulated in both livers and spleens, whilemacrophage receptor
with collagenous structure (Marco) was upregulated in livers but
downregulated in spleens. We confirmed latency-specific differ-
ential expression for 7 of 10 genes and 14 of 18 predictions. We
found that Gbp1, Igtp, Iigp1,Marco, Syk, and Vcam1 but not Batf
or Plek were differentially expressed in the livers of latently in-
fectedmice and that Gbp1, IFN-, Igtp, Iigp1,Marco, and Syk but
not Batf, Il18rap, Plek, or Vcam1 were differentially expressed in
the spleens of latently infectedmice (Fig. 2). These results demon-
strate that our computational analyses specifically identifiedmany
genes differentially expressed in latently infected animals.
To identify the genes with the largest differential gene expres-
sion in latently infected animals, we calculated the signal-to-noise
ratio for each gene in each tissue by determining the difference
between the mean fold change of results for MHV68 versus those
for mock and ORF73.stop versus mock, scaled by the variance
between these (i.e., the sum of the standard deviations). For genes
detected by multiple probes, we averaged the fold change across
the probes and then computed the signal-to-noise ratio using the
average fold change values. Genes were ranked in order of the
absolute value of the signal-to-noise ratio. We selected the top 50
genes identified in this signal-to-noise analysis and identified
those that overlapped with the genes detected as statistically sig-
nificant in our previous analyses (see Data Set S1 in the supple-
mental material). This conservative approach generated a set of
genes (Tables 2 to 4) that exhibit infection-related changes in ex-
pression, which we then used as a substrate for considering the
biological pathways that might be altered by chronic viral infec-
tion in different organs.
Distinct pathways are regulated by latent viral infection in
livers and spleens. Using hierarchical clustering, we found that
the differentially expressed genes covaried by organ (Fig. 1). We
identified a subset of genes that were primarily differentially ex-
pressed in the liver and a separate subset of genes that were pri-
marily differentially expressed in the spleen, with modest overlap
between the two tissues. To determine the specific cellular path-
ways altered in the organs of latently infected mice, we used
MSigDB to evaluate pathway enrichment by gene set enrichment
analysis (15). To determine the pathways enriched by latent viral
infection, we used factorial analysis to determine the differentially
expressed genes in each organ inWTMHV68-infectedmice com-
pared to those for mock-infected mice and then removed any
genes that were also differentially expressed in ORF73.stop-in-
fected mice. The numbers of genes that were differentially ex-
pressed in bothWTMHV68 andORF73.stop-infectedmice com-
pared to those formock infection weremodest (65 for liver, 15 for









































































































FIG 2 Validation of microarray analyses by qRT-PCR. RNA pooled from three to four mice per condition was treated with Turbo DNase (Life Technologies)
before cDNA synthesis using 1 g RNA, oligo(dT)12-18, and Superscript II reverse transcriptase (Life Technologies). qPCR was performed with cDNA from
livers (A) or spleens (B) using Power SYBR green master mix (Applied Biosystems) with the indicated gene-specific primers (Table 1). Data were collected from
4 independent experiments. Transcript levels were normalized to the level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) within each sample and
compared to the level in mock-infected mice using theCTmethod (where CT is the threshold cycle). Data are presented as means	 SEM. Statistical analyses
were performed by using the Mann-Whitney U test. , P 0.05; ns, not significant; nd, could not reliably detect target.
TABLE 1 Primers used in this study for qRT-PCR
Target
Primer sequencea















a F, forward; R, reverse.
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in the spleens of latently infected mice, we found that most genes
were associated with cell cycle pathways (Fig. 3A). This is consis-
tent with a previous report of differential gene expression in the
spleens of mice infected with MHV68, the betaherpesvirus, mu-
rine cytomegalovirus (MCMV), or the human alphaherpesvirus,
herpes simplex virus (HSV) (14). In contrast, of the 538 genes
differentially expressed in the livers of latently infectedmice, most
differentially expressed genes were associated with immune sig-
naling and immune response pathways, including interferon sig-
naling (Fig. 3B). The immune-related gene expression changes
detected in the liver were consistent with histological sections in
which foci of inflammatory cells were visible from mice infected
with WT MHV68 but not ORF73.stop virus or mock-infected
mice and likely reflected the immigration of inflammatory cells
rather than changes in resident hepatocytes (data not shown).
Because of the potential of diurnal gene regulation as a confound-
ing factor and the fact that the circadian rhythm was identified as
a significant pathway for differentially expressed genes in WT
MHV68-infected livers compared to livers from mock-infected
mice, we identified the circadian genes (Clock, Cpt1a, Elovl3,
Per1, and Per2 genes) that were differentially expressed in the
livers of latently infectedmice and repeated pathway analysis with
these removed to test their effect on latency-specific pathways.
The pathway of genes involved in platelet activation, signaling,
and aggregation was no longer statistically significant. The num-
ber of genes in the overlap with the pathway of genes involved in
metabolism of lipids and lipoproteins decreased by 3, and the
negative log of the q value decreased to 4.0915 from 5.9586. All of
the other pathwayswere insensitive to the removal of the circadian
clock genes. Although there were few genes whose expression
changed in the brains of latently infected mice (n 32), many of
the genes altered in the brain were also differentially expressed in
TABLE 2 Genes most differentially expressed in spleens of latently infected mice
Gene IDa Gene name
Signal-to-noise
ratio
Up or down relative
to ORF73.stop
CXCL9 Chemokine (C-X-C motif) ligand 9 22.9176 Up
SAA3 Serum amyloid A3 14.5842 Up
TTC39C Tetratricopeptide repeat domain 39C 10.3055 Up
GBP1 Guanylate binding protein 1, interferon inducible 10.1534 Up
IGTP Interferon gamma-induced GTPase 10.0122 Up
TIMP1 Tissue inhibitor of metalloproteinase 1 9.8577 Up
GZMB Granzyme B 8.3171 Up
MELK Maternal embryonic leucine zipper kinase 7.8645 Up
INCENP Inner centromere protein 7.499 Up
GPNMB Glycoprotein (transmembrane) nmb 7.1763 Up
AA467197 Expressed sequence AA467197 6.9617 Up
OSBPL3 Oxysterol binding protein-like 3 6.7681 Up
MKI67 Antigen identified by monoclonal antibody Ki 67 6.5786 Up
FABP5 Fatty acid binding protein 5, epidermal 6.5125 Up
IFNG Interferon gamma 6.4947 Up
RRM2 Ribonucleotide reductase M2 5.999 Up
MARCO Macrophage receptor with collagenous structure -5.7155 Down
GBP2 Guanylate binding protein 2 5.6835 Up
2410003J06RIK Mageb16 melanoma antigen family B, 16 5.6572 Up
XDH Xanthine dehydrogenase 5.5757 Up
STX3 Syntaxin 3 5.2772 Up
BHLHE40 Basic helix-loop-helix family, member e40 5.2416 Up
IL1RL1 Interleukin 1 receptor-like 1 5.1771 Up
CDC45L Cell division cycle 45 5.1685 Up
TRAFD1 TRAF type zinc finger domain containing 1 5.126 Up
TAP1 Transporter 1, ATP-binding cassette, subfamily B (MDR/TAP) 5.1003 Up
PARP9 Poly(ADP-ribose) polymerase family, member 9 4.9727 Up
CDC6 Cell division cycle 6 4.9208 Up
IIGP1 Interferon-inducible GTPase 1 4.9031 Up
IRG1 Immunoresponsive gene 1 4.8747 Up
PDCD1 Programmed cell death 1 4.8335 Up
RACGAP1 Rac GTPase-activating protein 1 4.7826 Up
HK2 Hexokinase 2 4.766 Up
CDKN1A Cyclin-dependent kinase inhibitor 1A (P21) 4.6531 Up
KIF4 Kinesin family member 4 4.6377 Up
UBAC1 Ubiquitin-associated domain-containing 1 4.6097 Up
UPP1 Uridine phosphorylase 1 4.5889 Up
DTX1 Deltex 1 homolog 4.5719 Down
CLEC4D C-type lectin domain family 4, member d 4.5384 Up
PDCD1LG2 Programmed cell death 1 ligand 2 4.5238 Up
STAT1 Signal transducer and activator of transcription 1 4.4588 Up
a ID, identifier.
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the liver or spleen of latently infected mice (see Fig. 1). The path-
ways significantly enriched in brains of latently infectedmice were
predominantly related to the immune system and interferon sig-
naling (Fig. 3C). Finally, we tested what pathways were enriched
across multiple tissues. We found that there were 109 genes that
were differentially expressed in both livers and spleens of latently
infected mice. The immune system generally and interferon sig-
naling specifically were the most significant pathways for these
TABLE 3 Genes most differentially expressed in livers of latently infected mice
Gene IDa Gene name
Signal-to-noise
ratio
Up or down relative
to ORF73.stop
IGTP Interferon gamma induced GTPase 7.3767 Up
MS4A4B Membrane-spanning 4 domains, subfamily A, member 4B 6.1604 Up
IIGP1 Interferon inducible GTPase 1 5.726 Up
STAT1 Signal transducer and activator of transcription 1 5.4494 Up
PTPN18 Protein tyrosine phosphatase, non-receptor type 18 5.4011 Up
FYB FYN binding protein 5.0647 Up
H2-Q7 Histocompatibility 2, Q region locus 7 5.013 Up
LY6A Lymphocyte antigen 6 complex, locus A 4.7926 Up
LCK Lymphocyte protein tyrosine kinase 4.7378 Up
SAA3 Serum amyloid A 3 4.6449 Up
GZMK Granzyme K 4.6062 Up
GZMA Granzyme A 4.2374 Up
GPR65 G-protein-coupled receptor 65 4.142 Up
BC023105 cDNA sequence BC023105 4.0748 Up
RGS1 Regulator of G-protein signaling 1 4.0444 Up
MPA2L Guanylate binding protein 6 4.022 Up
LST1 Leukocyte specific transcript 1 3.9534 Up
SAMHD1 SAM domain and HD domain, 1 3.9515 Up
S100A4 S100 calcium binding protein A4 3.9262 Up
GBP8 Guanylate-binding protein 8 3.8212 Up
ZBP1 Z-DNA binding protein 1 3.8156 Up
PITPNM1 Phosphatidylinositol transfer protein, membrane-associated 1 3.752 Up
FCGR4 Fc receptor, IgG, low affinity IV 3.678 Up
TAP1 Transporter 1, ATP-binding cassette, subfamily B (MDR/TAP) 3.5956 Up
PTGER4 Prostaglandin E receptor 4 (subtype EP4) 3.5583 Up
CAR14 Carbonic anhydrase 14 -3.4574 Down
ADCY7 Adenylate cyclase 7 3.4362 Up
GBP2 Guanylate binding protein 2 3.373 Up
CCL5 Chemokine (C-C motif) ligand 5 3.3726 Up
H2-AA Histocompatibility 2, class II antigen A, alpha 3.3344 Up
PSMB8 Proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) 3.2619 Up
H2-K1 Histocompatibility 2, K1, K region 3.2481 Up
S100A6 S100 calcium binding protein A6 (calcyclin) 3.2016 Up
EPB4.1L3 Erythrocyte protein band 4.1-like 3 3.15 Up
LAPTM5 Lysosome-associated protein transmembrane 5 3.1224 Up
a ID, identifier.





Up or down relative
to ORF73.stop
IIGP1 Interferon-inducible GTPase 1 8.358 Up
GBP2 Guanylate binding protein 2 6.2147 Up
H2-Q7 Histocompatibility 2, Q region locus 7 5.3892 Up
H2-K1 Histocompatibility 2, K1, K region 4.5909 Up
GBP6 Guanylate binding protein 6 4.0888 Up
CCL5 Chemokine (C-C motif) ligand 5 3.6399 Up
MS4A4B Membrane-spanning 4 domains, subfamily A, member 4B 3.2078 Up
IGTP Interferon gamma-induced GTPase 3.1533 Up
H2-EB1 Histocompatibility 2, class II antigen E beta 3.1481 Up
MPA2L Guanylate binding protein 6 2.5005 Up
CXCL9 Chemokine (C-X-C motif) ligand 9 2.4388 Up
H2-AA Histocompatibility 2, class II antigen A, alpha 2.414 Up
PSMB9 Proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) 1.9199 Up
PLAC8 Placenta-specific 8 0.9556 Up
a ID, identifier.
Canny et al.
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FIG3 Pathway analysis of differentially expressed genes in latently infectedmice. Gene overlap analyses of differentially expressed genes in spleens (A), livers (B),
or brains (C) of MHV68-infected mice. A list of latent infection-specific differentially expressed genes was identified by comparing MHV68-infected mice to
mock-infected mice and then removing genes that overlapped with those differentially expressed for ORF73.stop-infected mice compared to expression for
mock-infected mice. Pathways were identified using MSigDB’s Canonical Pathway gene set. The 50 most significant pathways for spleens (A) or livers (B) are
displayed. The x axis represents the q value, indicating the significance of enrichment for a given gene set. The values are plotted on a negative log10 scale. Gene
sets with values of1.3 (q 0.05) were significantly enriched.
Latent MHV68 Alters Host Transcription
January 2014 Volume 88 Number 1 jvi.asm.org 735
 o
n
 January 28, 2014 by W






overlapping genes (data not shown). Taken together, these results
demonstrate that latent viral infection differentially altered host
gene expression specifically by tissue type, suggesting that there
are distinct tissue responses to the host inflammatory response
induced by chronic infection and that themodest number of com-
mon gene expression changes across tissues may be largely attrib-
utable to chronic interferon signaling (2).
Differentially expressed genes are significantly associated
with genes regulated by the cytokine gamma interferon. IFN-
is required for controlling MHV68 reactivation from latency and
persistent viral replication and is elevated in the serum of latently
infected mice (2, 16–18). Previous work suggested that IFN- is
critical to latency-induced cross-protection against bacterial chal-
lenges and that central nervous system (CNS)-infiltrating T cells
in MHV68-exacerbated EAE produce elevated levels of IFN- (2,
7). Our microarray pathway analysis also confirmed that the
IFN- pathway was one of the most significantly enriched path-
ways in livers and brains of latently infectedmice. To confirm that
host genes induced in the setting of chronic MHV68 infection are
also regulated by IFN-, we compared our list of genes differen-
tially expressed in mice infected with WT MHV68 (relative to
expression in mock-infected mice) to a list of IFN--regulated
genes in murine bone marrow-derived macrophages (19). We
found that there was significant overlap between IFN--regulated
genes in bone marrow-derived macrophages and tissues from
MHV68-infected mice. Of the 359 genes regulated by IFN-, 59
were regulated in the livers (P 2.4390e27), 72 were regulated
in the spleens (P  7.4127e33), and 12 were regulated in the
brains (P 1.8151e13) of latently infected mice (Fig. 4; see also
Data Set S2 in the supplemental material). Many of the most dif-
ferentially expressed genes in all three tissues from latently in-
fected mice (Tables 2 to 4) are known to be induced by IFN-,
including genes encoding the Igtp, Iigp1, Gbps, Ccl5, Cxcl9, and
MHCmolecules. IFN- itself was significantly upregulated in the
latently infected mouse spleen (Fig. 2 and Table 2), an organ in
which significantly reduced Listeria and Yersinia titers are ob-
served in latently infected animals, suggesting a mechanism by
which latently infected mice resist lethal bacterial challenges (2).
Interestingly, the key IFN- signaling molecule, Stat1, was one of
the most upregulated genes in both livers and spleens of latently
infectedmice (Tables 2 and 3). This suggests that active interferon
signaling was also present in the livers of latently infected mice
where Listeria titers are reduced (2). These results suggest that
many of the genes differentially expressed in latently infectedmice
were a result of elevated IFN- levels in the host, which have been
detected during chronic MHV68 infection and are mechanisti-
cally important to latency-induced cross-protection (2).
EAE exacerbation by latentMHV68 is associated not only with
IFN- but also with increased inflammatory infiltration into the
CNS and elevated serum levels of the chemokines Ccl5 and Cxcl9,










































































FIG 4 Overlap of genes regulated by IFN- and latent viral infection. Heat
mapof differentially expressed genes in livers, spleens, or brains fromMHV68-
infectedmice (compared tomock-infectedmice) that significantly overlapped
with genes altered by IFN- in bone marrow-derived macrophages. The heat
map displays the fold change relative to results for mock-infected mice, with
red representing the row maximum and blue the row minimum value. Statis-
tical significance was assessed by a hypergeometric test. Nominal P values were
used.
Canny et al.
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unable to detect these chemokines in the CNS of latently infected
mice, Ccl5 and Cxcl9 are significantly elevated inmouse sera from
latently infected mice at the onset of EAE symptoms (7). Impor-
tantly, we detected Ccl5 andCxcl9 as two of themost differentially
expressed transcripts in the brains of latently infectedmice (Table
4). These data suggest that elevated expression of Ccl5 and Cxcl9
in the brain during latent infection may induce T cell migration
into the CNS, leading to augmented EAE symptoms.
Activatedmacrophages have been implicated in severalmodels
of latency-induced cross-protection, including challenges with
bacteria and influenza virus (2, 20). Specifically, thesemodels have
identified activated macrophages as those expressing increased
major histocompatibility complex (MHC) class II molecules.
Genes encoding MHC class II molecules, specifically H2-Aa and
H2-Eb1, were among the most highly differentially expressed
genes in the livers and brains of latently infected mice (Tables 3
and 4). These data confirm that latent MHV68 infection can in-
duce upregulation of MHC class II molecules in multiple organs
with implications for cross-protection against a range of infec-
tious challenges.
Here, we have shown that chronic herpesvirus infection can
profoundly alter gene expression in the host in a tissue-specific
manner. The observed host transcriptional changes induced by
latent infection were predominantly changes in immune-related
genes. However, the specific genes and pathways induced in la-
tently infected animals differed by tissue type. Whether this was
due to local differences in the inflammatory milieu or differential
tissue responses to the same stimulus is unknown.However, given
the differential effects of interferons and interferon-regulated
molecules in different cell types (21–26), it is reasonable to hy-
pothesize that the differences observed here were the result of
differential cell responses and cell composition in specific organs.
It is interesting to speculate onwhat effects the gene expression
changes induced by latent viral infection might have on the func-
tion of host tissues. Previous studies delineating a role forMHV68
in exacerbating EAE pathology (7, 8), in addition to the impor-
tance of IFN- in EAE pathogenesis (27) and in the induction of
many of the changes observed here, suggest that the gene expres-
sion changes induced in the setting of latent viral infection may
alter the course of chronic disease pathogenesis. In a previous
study of splenic gene expression changes in response to HSV,
MCMV, orMHV68 infection, the authors identified virus-specific
changes (14), suggesting that there may be important, dynamic,
and complex gene expression changes in a human host infected
with multiple viruses. Taken together, these results demonstrate
that chronic viral infection can have profound and distinct effects
on the host, with potential implications for tissue function and
pathogenesis of chronic disease in susceptible hosts.
Microarray data accession number. Microarray data have
been deposited in GeoArchive, series number GSE51365.
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